Protein levels may identify high-risk kidney transplant patients

09/2/2013 | Nurse.com

A study in the American Journal of Transplantation revealed that evaluating the levels of the CXCL9 protein in the urine of kidney transplant patients may help identify those at risk of having kidney injury following transplant. "A noninvasive urine test to accurately monitor the risk of kidney rejection could dramatically reduce the need for biopsies and possibly enable doctors to safely reduce immunosuppressive therapy in some patients," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which funded the study.

View Full Article in:

Nurse.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA